Global End Stage Renal Disease Treatment Market Research Report 2023(Status and Outlook)
Report Overview
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
The Global End Stage Renal Disease Treatment Market Size was estimated at USD 55330.00 million in 2022 and is projected to reach USD 80487.40 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global End Stage Renal Disease Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global End Stage Renal Disease Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the End Stage Renal Disease Treatment market in any manner.
Global End Stage Renal Disease Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Market Segmentation (by Type)
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Market Segmentation (by Application)
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the End Stage Renal Disease Treatment Market
Overview of the regional outlook of the End Stage Renal Disease Treatment Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of End Stage Renal Disease Treatment
- 1.2 Key Market Segments
- 1.2.1 End Stage Renal Disease Treatment Segment by Type
- 1.2.2 End Stage Renal Disease Treatment Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 End Stage Renal Disease Treatment Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global End Stage Renal Disease Treatment Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global End Stage Renal Disease Treatment Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 End Stage Renal Disease Treatment Market Competitive Landscape
- 3.1 Global End Stage Renal Disease Treatment Sales by Manufacturers (2018-2023)
- 3.2 Global End Stage Renal Disease Treatment Revenue Market Share by Manufacturers (2018-2023)
- 3.3 End Stage Renal Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global End Stage Renal Disease Treatment Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers End Stage Renal Disease Treatment Sales Sites, Area Served, Product Type
- 3.6 End Stage Renal Disease Treatment Market Competitive Situation and Trends
- 3.6.1 End Stage Renal Disease Treatment Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest End Stage Renal Disease Treatment Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 End Stage Renal Disease Treatment Industry Chain Analysis
- 4.1 End Stage Renal Disease Treatment Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of End Stage Renal Disease Treatment Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 End Stage Renal Disease Treatment Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global End Stage Renal Disease Treatment Sales Market Share by Type (2018-2023)
- 6.3 Global End Stage Renal Disease Treatment Market Size Market Share by Type (2018-2023)
- 6.4 Global End Stage Renal Disease Treatment Price by Type (2018-2023)
- 7 End Stage Renal Disease Treatment Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global End Stage Renal Disease Treatment Market Sales by Application (2018-2023)
- 7.3 Global End Stage Renal Disease Treatment Market Size (M USD) by Application (2018-2023)
- 7.4 Global End Stage Renal Disease Treatment Sales Growth Rate by Application (2018-2023)
- 8 End Stage Renal Disease Treatment Market Segmentation by Region
- 8.1 Global End Stage Renal Disease Treatment Sales by Region
- 8.1.1 Global End Stage Renal Disease Treatment Sales by Region
- 8.1.2 Global End Stage Renal Disease Treatment Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America End Stage Renal Disease Treatment Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe End Stage Renal Disease Treatment Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific End Stage Renal Disease Treatment Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America End Stage Renal Disease Treatment Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa End Stage Renal Disease Treatment Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Fresenius
- 9.1.1 Fresenius End Stage Renal Disease Treatment Basic Information
- 9.1.2 Fresenius End Stage Renal Disease Treatment Product Overview
- 9.1.3 Fresenius End Stage Renal Disease Treatment Product Market Performance
- 9.1.4 Fresenius Business Overview
- 9.1.5 Fresenius End Stage Renal Disease Treatment SWOT Analysis
- 9.1.6 Fresenius Recent Developments
- 9.2 DaVita
- 9.2.1 DaVita End Stage Renal Disease Treatment Basic Information
- 9.2.2 DaVita End Stage Renal Disease Treatment Product Overview
- 9.2.3 DaVita End Stage Renal Disease Treatment Product Market Performance
- 9.2.4 DaVita Business Overview
- 9.2.5 DaVita End Stage Renal Disease Treatment SWOT Analysis
- 9.2.6 DaVita Recent Developments
- 9.3 Baxter
- 9.3.1 Baxter End Stage Renal Disease Treatment Basic Information
- 9.3.2 Baxter End Stage Renal Disease Treatment Product Overview
- 9.3.3 Baxter End Stage Renal Disease Treatment Product Market Performance
- 9.3.4 Baxter Business Overview
- 9.3.5 Baxter End Stage Renal Disease Treatment SWOT Analysis
- 9.3.6 Baxter Recent Developments
- 9.4 Nipro
- 9.4.1 Nipro End Stage Renal Disease Treatment Basic Information
- 9.4.2 Nipro End Stage Renal Disease Treatment Product Overview
- 9.4.3 Nipro End Stage Renal Disease Treatment Product Market Performance
- 9.4.4 Nipro Business Overview
- 9.4.5 Nipro End Stage Renal Disease Treatment SWOT Analysis
- 9.4.6 Nipro Recent Developments
- 9.5 B. Braun
- 9.5.1 B. Braun End Stage Renal Disease Treatment Basic Information
- 9.5.2 B. Braun End Stage Renal Disease Treatment Product Overview
- 9.5.3 B. Braun End Stage Renal Disease Treatment Product Market Performance
- 9.5.4 B. Braun Business Overview
- 9.5.5 B. Braun End Stage Renal Disease Treatment SWOT Analysis
- 9.5.6 B. Braun Recent Developments
- 9.6 Asahi Kasei
- 9.6.1 Asahi Kasei End Stage Renal Disease Treatment Basic Information
- 9.6.2 Asahi Kasei End Stage Renal Disease Treatment Product Overview
- 9.6.3 Asahi Kasei End Stage Renal Disease Treatment Product Market Performance
- 9.6.4 Asahi Kasei Business Overview
- 9.6.5 Asahi Kasei Recent Developments
- 9.7 Nikkiso
- 9.7.1 Nikkiso End Stage Renal Disease Treatment Basic Information
- 9.7.2 Nikkiso End Stage Renal Disease Treatment Product Overview
- 9.7.3 Nikkiso End Stage Renal Disease Treatment Product Market Performance
- 9.7.4 Nikkiso Business Overview
- 9.7.5 Nikkiso Recent Developments
- 9.8 WEGO
- 9.8.1 WEGO End Stage Renal Disease Treatment Basic Information
- 9.8.2 WEGO End Stage Renal Disease Treatment Product Overview
- 9.8.3 WEGO End Stage Renal Disease Treatment Product Market Performance
- 9.8.4 WEGO Business Overview
- 9.8.5 WEGO Recent Developments
- 9.9 Newsol
- 9.9.1 Newsol End Stage Renal Disease Treatment Basic Information
- 9.9.2 Newsol End Stage Renal Disease Treatment Product Overview
- 9.9.3 Newsol End Stage Renal Disease Treatment Product Market Performance
- 9.9.4 Newsol Business Overview
- 9.9.5 Newsol Recent Developments
- 9.10 Mayo Clinic
- 9.10.1 Mayo Clinic End Stage Renal Disease Treatment Basic Information
- 9.10.2 Mayo Clinic End Stage Renal Disease Treatment Product Overview
- 9.10.3 Mayo Clinic End Stage Renal Disease Treatment Product Market Performance
- 9.10.4 Mayo Clinic Business Overview
- 9.10.5 Mayo Clinic Recent Developments
- 9.11 Guangdong Biolight
- 9.11.1 Guangdong Biolight End Stage Renal Disease Treatment Basic Information
- 9.11.2 Guangdong Biolight End Stage Renal Disease Treatment Product Overview
- 9.11.3 Guangdong Biolight End Stage Renal Disease Treatment Product Market Performance
- 9.11.4 Guangdong Biolight Business Overview
- 9.11.5 Guangdong Biolight Recent Developments
- 9.12 Medtronic
- 9.12.1 Medtronic End Stage Renal Disease Treatment Basic Information
- 9.12.2 Medtronic End Stage Renal Disease Treatment Product Overview
- 9.12.3 Medtronic End Stage Renal Disease Treatment Product Market Performance
- 9.12.4 Medtronic Business Overview
- 9.12.5 Medtronic Recent Developments
- 9.13 Sanxin Medtec
- 9.13.1 Sanxin Medtec End Stage Renal Disease Treatment Basic Information
- 9.13.2 Sanxin Medtec End Stage Renal Disease Treatment Product Overview
- 9.13.3 Sanxin Medtec End Stage Renal Disease Treatment Product Market Performance
- 9.13.4 Sanxin Medtec Business Overview
- 9.13.5 Sanxin Medtec Recent Developments
- 9.14 Jafron Biomedical
- 9.14.1 Jafron Biomedical End Stage Renal Disease Treatment Basic Information
- 9.14.2 Jafron Biomedical End Stage Renal Disease Treatment Product Overview
- 9.14.3 Jafron Biomedical End Stage Renal Disease Treatment Product Market Performance
- 9.14.4 Jafron Biomedical Business Overview
- 9.14.5 Jafron Biomedical Recent Developments
- 9.15 SWS Hemodialysis Care
- 9.15.1 SWS Hemodialysis Care End Stage Renal Disease Treatment Basic Information
- 9.15.2 SWS Hemodialysis Care End Stage Renal Disease Treatment Product Overview
- 9.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Product Market Performance
- 9.15.4 SWS Hemodialysis Care Business Overview
- 9.15.5 SWS Hemodialysis Care Recent Developments
- 9.16 Tianyi Medical
- 9.16.1 Tianyi Medical End Stage Renal Disease Treatment Basic Information
- 9.16.2 Tianyi Medical End Stage Renal Disease Treatment Product Overview
- 9.16.3 Tianyi Medical End Stage Renal Disease Treatment Product Market Performance
- 9.16.4 Tianyi Medical Business Overview
- 9.16.5 Tianyi Medical Recent Developments
- 10 End Stage Renal Disease Treatment Market Forecast by Region
- 10.1 Global End Stage Renal Disease Treatment Market Size Forecast
- 10.2 Global End Stage Renal Disease Treatment Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe End Stage Renal Disease Treatment Market Size Forecast by Country
- 10.2.3 Asia Pacific End Stage Renal Disease Treatment Market Size Forecast by Region
- 10.2.4 South America End Stage Renal Disease Treatment Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of End Stage Renal Disease Treatment by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global End Stage Renal Disease Treatment Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of End Stage Renal Disease Treatment by Type (2024-2029)
- 11.1.2 Global End Stage Renal Disease Treatment Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of End Stage Renal Disease Treatment by Type (2024-2029)
- 11.2 Global End Stage Renal Disease Treatment Market Forecast by Application (2024-2029)
- 11.2.1 Global End Stage Renal Disease Treatment Sales (K MT) Forecast by Application
- 11.2.2 Global End Stage Renal Disease Treatment Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook